You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
化学療法剤、分子標的薬、cyclooxygenase阻害剤を含む様々な薬剤を使用し治療を行った犬の膀胱尿路上皮癌(移行上皮癌)の1例
|
|---|---|
| Published in |
Journal of Japan Veterinary Cancer Society, May 2023
|
| DOI | 10.12951/jvcs.2021-005 |
| Authors |
児玉 和仁, 児玉 恵子 |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#23,196,947
of 25,852,155 outputs
Outputs from Journal of Japan Veterinary Cancer Society
#17
of 21 outputs
Outputs of similar age
#335,951
of 395,348 outputs
Outputs of similar age from Journal of Japan Veterinary Cancer Society
#1
of 1 outputs
Altmetric has tracked 25,852,155 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 21 research outputs from this source. They receive a mean Attention Score of 0.5. This one scored the same or higher as 4 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 395,348 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them